Normalization of the Vasculature for Treatment of Cancer and Other Diseases

Physiological Reviews - Tập 91 Số 3 - Trang 1071-1121 - 2011
Shom Goel1, Dan G. Duda2, Lei Xu2, Lance L. Munn2, Yves Boucher2, Dai Fukumura2, Rakesh K. Jain2
1Edwin L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
2Edwin L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

Tóm tắt

New vessel formation (angiogenesis) is an essential physiological process for embryologic development, normal growth, and tissue repair. Angiogenesis is tightly regulated at the molecular level. Dysregulation of angiogenesis occurs in various pathologies and is one of the hallmarks of cancer. The imbalance of pro- and anti-angiogenic signaling within tumors creates an abnormal vascular network that is characterized by dilated, tortuous, and hyperpermeable vessels. The physiological consequences of these vascular abnormalities include temporal and spatial heterogeneity in tumor blood flow and oxygenation and increased tumor interstitial fluid pressure. These abnormalities and the resultant microenvironment fuel tumor progression, and also lead to a reduction in the efficacy of chemotherapy, radiotherapy, and immunotherapy. With the discovery of vascular endothelial growth factor (VEGF) as a major driver of tumor angiogenesis, efforts have focused on novel therapeutics aimed at inhibiting VEGF activity, with the goal of regressing tumors by starvation. Unfortunately, clinical trials of anti-VEGF monotherapy in patients with solid tumors have been largely negative. Intriguingly, the combination of anti-VEGF therapy with conventional chemotherapy has improved survival in cancer patients compared with chemotherapy alone. These seemingly paradoxical results could be explained by a “normalization” of the tumor vasculature by anti-VEGF therapy. Preclinical studies have shown that anti-VEGF therapy changes tumor vasculature towards a more “mature” or “normal” phenotype. This “vascular normalization” is characterized by attenuation of hyperpermeability, increased vascular pericyte coverage, a more normal basement membrane, and a resultant reduction in tumor hypoxia and interstitial fluid pressure. These in turn can lead to an improvement in the metabolic profile of the tumor microenvironment, the delivery and efficacy of exogenously administered therapeutics, the efficacy of radiotherapy and of effector immune cells, and a reduction in number of metastatic cells shed by tumors into circulation in mice. These findings are consistent with data from clinical trials of anti-VEGF agents in patients with various solid tumors. More recently, genetic and pharmacological approaches have begun to unravel some other key regulators of vascular normalization such as proteins that regulate tissue oxygen sensing (PHD2) and vessel maturation (PDGFRβ, RGS5, Ang1/2, TGF-β). Here, we review the pathophysiology of tumor angiogenesis, the molecular underpinnings and functional consequences of vascular normalization, and the implications for treatment of cancer and nonmalignant diseases.

Từ khóa


Tài liệu tham khảo

10.1172/JCI200318549

10.1038/sj.onc.1207095

10.1093/jnci/6.1.73

10.1200/JCO.2010.30.0855

10.1200/JCO.2000.18.11.2201

10.1038/nm1095-1024

Ansiaux R, 2005, Clin Cancer Res, 11, 743, 10.1158/1078-0432.743.11.2

10.1038/nrm2639

10.2353/ajpath.2010.100594

10.1016/S0092-8674(00)81618-9

10.1016/j.cell.2010.01.033

Baish JW, 2000, Cancer Res, 60, 3683

10.1073/pnas.1018154108

10.1200/JCO.2009.26.3988

10.1016/j.ccr.2006.11.021

10.1016/j.ijrobp.2009.07.120

Baum O, 2010, Microcirculation, 17, 447

10.1016/0026-2862(89)90074-5

10.1016/0026-2862(90)90023-K

10.1016/0026-2862(91)90003-T

10.1016/0026-2862(91)90026-8

10.1172/JCI5028

10.1023/A:1006363215260

10.1158/1078-0432.CCR-08-0212

10.3816/CCC.2009.n.025

10.1172/JCI21378

10.1016/j.yexcr.2005.11.024

10.1073/pnas.2135406100

10.1016/S0002-9440(10)63868-0

10.1016/j.jhep.2010.03.021

10.1038/423593a

Boucher Y, 1990, Cancer Res, 50, 4478

Boucher Y, 1991, Cancer Res, 51, 6691

10.1038/bjc.1997.148

10.1016/j.ophtha.2009.06.048

10.1016/j.ophtha.2009.06.045

10.1080/00016480310005101

Browder T, 2000, Cancer Res, 60, 1878

10.1038/nm879

10.1158/1535-7163.MCT-09-0554

10.1101/gad.1256804

10.1016/S1535-6108(03)00187-9

10.1148/radiol.2453061889

10.1158/1078-0432.CCR-08-0593

10.1038/380435a0

10.1038/35025220

10.1038/nature10144

10.1038/87904

10.1016/j.ccr.2005.09.005

10.1097/00005537-200312000-00014

10.1097/00129492-200501000-00017

10.1371/journal.pone.0006539

10.1158/1078-0432.CCR-09-3073

10.1038/sj.bjc.6605727

10.1096/fj.02-0340fje

10.1038/nrc2868

10.1152/ajpheart.00879.2008

10.1053/j.seminoncol.2003.08.013

10.1158/0008-5472.CAN-10-0012

Cohen-Jonathan E, 2001, Cancer Res, 61, 2289

10.1073/pnas.0607538103

10.1016/j.tripleo.2004.06.075

10.2741/3616

10.1016/j.devcel.2009.01.004

Delmas C, 2003, Clin Cancer Res, 9, 6062

10.1038/nrc2748

10.1371/journal.pone.0005123

10.1158/0008-5472.CAN-10-2602

10.1016/j.jpedsurg.2006.09.052

10.1158/1078-0432.CCR-07-0278

10.1158/1541-7786.MCR-06-0259

10.1158/1078-0432.CCR-06-2441

10.1096/fj.05-4493com

10.1200/JCO.2005.04.2861

10.1158/1078-0432.CCR-10-2636

10.1634/theoncologist.2010-0029

10.1056/NEJM198612253152606

10.1016/j.ccr.2009.01.021

Ehrmann RL, 1968, J Natl Cancer Inst, 41, 1329

10.4161/cbt.7.7.5997

10.1038/nrc2403

Emblem KE, 2011, Proceedings of the 2011 Meeting of the International Soceity for Magnetic Resonance in Medicine

10.2353/ajpath.2009.090391

10.1161/ATVBAHA.108.179663

10.1038/nrc909

10.1038/380439a0

10.1016/j.cell.2007.08.038

10.1038/nrc2524

10.1215/15228517-2008-042

10.1056/NEJM197111182852108

10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y

Folkman MJ, 1962, Surg Forum, 13, 81

10.1126/science.270.5241.1500

10.1200/JCO.2008.19.8721

10.1111/j.1549-8719.2010.00029.x

10.1073/pnas.041359198

10.1016/S0092-8674(00)81731-6

10.1038/21218

10.1038/nm1096-1096

10.1002/eji.200425474

10.3109/10739689709146803

10.1007/s00441-003-0745-x

10.1200/JCO.2006.09.6305

10.1093/jnci/52.2.413

10.1093/jnci/56.2.305

10.1038/13524

Gorski DH, 1999, Cancer Res, 59, 3374

10.1016/j.jcmg.2009.10.009

10.1056/NEJMoa042760

10.1038/nature07424

Greenblatt M, 1968, J Natl Cancer Inst, 41, 111

Griffioen AW, 1996, Blood, 88, 667, 10.1182/blood.V88.2.667.bloodjournal882667

10.1097/00006982-200204000-00002

Gullino PM, 1982, Biomedical Thermology

Gullino PM, 1978, J Natl Cancer Inst, 61, 639

10.1158/0008-5472.CAN-05-2655

10.1038/nature06868

10.1016/j.cell.2011.02.013

10.1158/1078-0432.CCR-08-2568

Hansen-Algenstaedt N, 2000, Cancer Res, 60, 4556

10.1038/nrc704

10.1016/S0002-9440(10)65006-7

10.1038/nm0297-177

10.1016/S1470-2045(10)70132-7

10.1111/j.1365-2133.2007.07889.x

10.1158/0008-5472.CAN-05-0002

10.1073/pnas.1100446108

10.1073/pnas.95.16.9349

10.1073/pnas.95.8.4607

Hockel M, 1999, Cancer Res, 59, 4525

10.1093/jnci/93.4.266

10.1038/nrc2894

10.1158/1078-0432.CCR-10-2317

Huang X, 2002, Cancer Res, 62, 5727

10.1128/MCB.22.20.7004-7014.2002

10.1056/NEJMoa032691

Ide AG, 1939, Am J Radiol, 42, 891

10.1016/S0002-9440(10)63273-7

10.1084/jem.20022027

10.1038/416279b

10.1093/jnci/81.8.570

Jain RK, 1988, Cancer Res, 48, 2641

10.1038/nm0603-685

10.1126/science.1104819

10.1038/nm0901-987

10.1038/scientificamerican0108-56

Jain RK, 1988, Cancer Res, 48, 7022

10.1172/JCI200320087

10.1038/ncponc0403

10.1038/nrclinonc.2009.63

10.1038/ncpcardio0979

10.1073/pnas.95.18.10820

10.1038/nrclinonc.2010.139

10.1158/0008-5472.CAN-06-4102

10.1002/(SICI)1096-9896(199906)188:2<189::AID-PATH336>3.0.CO;2-N

10.1016/j.ijrobp.2010.03.027

Jonasch E, 2010, Cancer, 116, 57, 10.1002/cncr.24685

10.1158/1078-0432.CCR-09-0090

10.1200/JCO.2005.01.5388

10.1016/j.molcel.2008.04.009

10.1200/JCO.2008.19.9356

10.1172/JCI24015

10.1038/nm1730

10.1126/science.2479987

10.1038/nrc1369

10.1016/S0959-8049(00)00092-7

10.1073/pnas.1014480108

10.1038/362841a0

10.1038/nmeth.1440

10.1016/j.cytogfr.2005.05.002

10.1007/978-1-4615-0119-0_3

10.1016/j.ccr.2010.07.001

10.1038/428138a

10.1056/NEJMoa035655

Kozin SV, 2001, Cancer Res, 61, 39

10.1016/j.aanat.2010.01.005

10.1093/jnci/djm229

10.1038/nm.2131

Lee CG, 2000, Cancer Res, 60, 5565

10.1103/PhysRevLett.96.058104

Less JR, 1992, Cancer Res, 52, 6371

10.3109/10739689709148315

Less JR, 1991, Cancer Res, 51, 265

10.1126/science.2479986

Leunig M, 1992, Cancer Res, 52, 6553

10.1073/pnas.032074999

10.1158/1078-0432.CCR-06-1558

10.1158/1078-0432.CCR-10-2429

Liu F, 2008, Cancer Sci, 99, 2055, 10.1111/j.1349-7006.2008.00905.x

10.1158/1078-0432.CCR-10-2456

Lu-Emerson C, 2009, Rev Neurol Dis, 6, E81

Ma J, 2001, Cancer Res, 61, 5491

10.1161/01.ATV.0000282198.60701.94

Maione F, 2009, J Clin Invest, 119, 3356

10.1126/science.277.5322.55

10.1038/sj.bjc.6605203

10.1158/1078-0432.CCR-07-0374

10.1073/pnas.0908447106

10.1016/j.ccr.2011.02.005

10.1016/j.cell.2009.01.020

10.1172/JCI31334

10.1016/j.ijrobp.2009.12.010

10.1038/nm0996-992

10.1200/JCO.2010.30.2794

10.1016/0092-8674(93)90573-9

10.1056/NEJMoa072113

10.1016/S0002-9440(10)64920-6

10.1200/jco.2011.29.7_suppl.lba308

10.1161/01.CIR.99.13.1726

10.1200/jco.2010.28.15_suppl.5064

10.1038/sj.bjc.6604929

10.1084/jem.20021244

10.1158/0008-5472.CAN-05-0923

10.1158/0008-5472.CAN-08-3030

10.1006/mvre.1996.0041

10.1074/jbc.271.47.30290

10.1007/s00595-009-4020-y

10.1182/blood-2007-10-120337

10.1007/s00262-007-0441-x

10.1158/1535-7163.MCT-08-0182

10.1038/427695a

10.1016/j.ccr.2009.01.027

10.1016/j.ccr.2006.10.018

10.1006/mvre.1996.0025

10.1016/S1535-6108(03)00085-0

10.1056/NEJMoa0902579

10.1158/0008-5472.CAN-06-1239

10.1158/0008-5472.CAN-05-3090

10.1371/journal.pcbi.1000394

10.1038/nrc2895

10.1158/0008-5472.CAN-10-0507

10.1158/0008-5472.CAN-09-0657

10.1073/pnas.0914619107

10.1177/43.4.7534783

Quaegebeur A, 2010, Curr Top Microbiol Immunol, 810, 71

10.1016/S0065-2423(10)50006-4

10.1002/ajh.21745

10.1200/JCO.2007.14.5466

Relf M, 1997, Cancer Res, 57, 963

10.1038/nm0102-27

10.1002/pros.10035

10.1200/jco.2008.26.15_suppl.3543

Roh HD, 1991, Cancer Res, 51, 6695

10.1016/j.ccr.2010.11.009

10.1056/NEJMoa054481

10.1038/labinvest.3700252

10.1200/JCO.2007.14.9930

10.1056/NEJMoa061884

10.1158/0008-5472.CAN-10-0412

10.1016/j.aanat.2006.04.004

10.1073/pnas.150242297

Schlingemann RO, 1991, Am J Pathol, 138, 1335

10.1200/JCO.2008.16.1612

10.1158/0008-5472.CAN-08-1044

10.1073/pnas.0907550106

10.1016/j.canlet.2005.12.017

10.1038/onc.2009.441

10.1016/j.gde.2009.10.009

10.1128/MCB.12.12.5447

10.1126/science.6823562

10.1038/nbt1323

10.1158/0008-5472.CAN-10-0153

10.1158/0008-5472.CAN-08-2158

10.1158/0008-5472.CAN-09-0814

10.1113/jphysiol.1896.sp000596

10.1038/nature07445

Stohrer M, 2000, Cancer Res, 60, 4251

10.1007/s10439-007-9377-8

10.1016/S0092-8674(00)81813-9

10.2353/ajpath.2010.100059

10.1111/j.1349-7006.2007.00724.x

10.1089/jir.2008.0030

10.1200/JCO.2009.27.7723

10.1007/BF00437479

Teicher BA, 1995, Oncol Res, 7, 237

10.1007/BF00666043

10.1016/0006-291X(92)90483-2

10.1038/74725

10.1126/science.286.5449.2511

10.1158/0008-5472.CAN-04-0074

Tsukada K, 2009, 100th Annual Meeting of AACR

10.1002/jmri.20049

10.1016/j.ccr.2010.11.001

10.1200/JCO.2010.32.2701

10.1016/j.cell.2010.02.039

10.1161/01.ATV.0000178991.71605.18

10.1038/nm1087

10.1200/JCO.2007.12.2440

10.1074/jbc.270.3.1230

10.1172/JCI117857

10.1016/S1535-6108(03)00030-8

10.1093/annonc/mdp533

10.1016/j.jtbi.2009.04.005

10.1038/sj.bjc.6601005

10.1038/nm988

10.1200/JCO.2005.02.5635

10.1634/theoncologist.2010-0030

10.1200/JCO.2008.21.1771

Winkler F, 2004, Cancer Cell, 6, 553

10.1161/01.RES.81.4.567

10.1200/JCO.2010.32.5282

10.1158/0008-5472.CAN-09-3107

10.2307/3579620

10.1016/j.jbiomech.2009.01.009

10.1172/JCI25705

10.1158/0008-5472.CAN-09-2099

10.1158/0008-5472.CAN-08-2058

10.1038/35040568

10.1038/85655

10.1159/000087840

Yoshiji H, 1997, Cancer Res, 57, 3924

10.1073/pnas.0501444102

10.1167/iovs.07-1175

10.1073/pnas.93.25.14765

10.1073/pnas.0804123105

10.1182/blood-2002-06-1877

10.1038/nrc2458

10.1215/15228517-2008-088

10.1158/1078-0432.CCR-07-4544

10.1200/JCO.2008.20.9908

Thông tin
Thông tin xuất bản

Physiological Reviews

Tập 91 Số 3

1071-1121

Thông tin tác giả